DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹500 Cr | ₹611 Cr | ₹557 Cr | ₹437 Cr | ₹364 Cr |
What is the latest Total Non-Current Liabilities ratio of DIVIS LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹500 Cr |
| Mar2024 | ₹611 Cr |
| Mar2023 | ₹557 Cr |
| Mar2022 | ₹437 Cr |
| Mar2021 | ₹364 Cr |
How is Total Non-Current Liabilities of DIVIS LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹500 Cr | -18.17 | |
| Mar2024 | ₹611 Cr | 9.69 | |
| Mar2023 | ₹557 Cr | 27.60 | |
| Mar2022 | ₹437 Cr | 19.94 | |
| Mar2021 | ₹364 Cr | - | |
Compare Total Non-Current Liabilities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹159,908.0 Cr | -2% | -4.3% | 3.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,555.0 Cr | -1.5% | 1.6% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,073.0 Cr | -0.8% | 0.5% | 32% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,133.0 Cr | -2.7% | -1.6% | 6.9% | Stock Analytics | |
| CIPLA | ₹98,492.9 Cr | -3.9% | -9.1% | -18.4% | Stock Analytics | |
| MANKIND PHARMA | ₹82,039.3 Cr | -5.5% | -2% | -11.1% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -2% |
-4.3% |
3.3% |
| SENSEX | -2.6% |
-10.2% |
-1.6% |
You may also like the below Video Courses